| Literature DB >> 24040027 |
Xiuzhen Fan1, Dingge Li, Cheryl F Lichti, Thomas A Green.
Abstract
Our prior research has shown that environmental enrichment (i.e. rats reared in an environment with novel objects, social contact with conspecifics) produces a protective antidepressant-like phenotype in rats and decreases neurobiological effects of acute psychological stress. Although CREB activity has been identified as a major player, the downstream molecular mechanisms remain largely unexplored. Thus, the current study investigates proteomic differences in the accumbens of rats raised in an enriched condition (EC) versus those raised in an isolated control condition (IC) under basal conditions and after 30 min of acute restraint stress. Results showed that under basal conditions, EC rats generally expressed less mitochondria-related proteins, particularly those involved in TCA cycle and electron transport compared to IC rats. After 30 min of acute stress, EC rats displayed increased expression of energy metabolism enzymes (among others) while IC rats exhibited decreased expression of similar proteins. Further, network and pathway analyses also identified links to AKT signaling proteins, 14-3-3 family proteins, heat-shock proteins, and ubiquitin-interacting proteins. The protein ENO1 showed marked differential expression and regulation; EC rats expressed higher levels under basal conditions that increased subsequent to stress, while the basal IC expression was lower and decreased further still after stress. The results of this study define differential protein expression in a protective rat model for major depression and additionally identify a dynamic and coordinated differential response to acute stress between the two groups. These results provide new avenues for exploration of the molecular determinants of depression and the response to acute stress.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24040027 PMCID: PMC3767735 DOI: 10.1371/journal.pone.0073689
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The expression of significantly regulated proteins from cytosolic extracts of rat NAcc (P<0.05) comparing EC vs. IC basal expression (blue), IC stress (green), and EC stress (orange), which were analyzed by Progenesis SameSpots in CBB stained gels.
Proteins significantly regulated in the cytosolic fraction of rat NAcc in EC and IC rats.
| Spot ID no. | Protein name | Gene symbol | NCBI No. | Number of matched peptides | Coverage (%) | MOWSE score | Fold change |
|
| |||||||
| 1 | alpha-enolase isoform 1 | ENO1 | gi|158186649 | 8 | 29 | 258 | 1.2 |
| 2 | dihydropyrimidinase-related protein 2 | DPYSL2 | gi|40254595 | 8 | 22 | 144 | −1.9 |
| 3 | chaperonin 60 | HSPD1 | gi|1778213 | 4 | 11 | 94 | 2.6 |
| 4 | heat shock 70 kDa protein; Provisional | HSPA8 | gi|149041392 | 4 | 24 | 129 | 3.2 |
| 5 | Eno1 protein | ENO1 | gi|38649320 | 6 | 19 | 133 | 2.2 |
|
| |||||||
| 6 | Chain A, Rat Liver F1-Atpase | ATP5A1 | gi|6729934 | 10 | 23 | 578 | −2.0 |
| 7 | glyceraldehyde-3-phosphate dehydrogenase | GAPDH | gi|62653546 | 6 | 23 | 174 | −1.8 |
| 8 | glyceraldehyde-3-phosphate dehydrogenase | GAPDH | gi|62653546 | 4 | 20 | 207 | −1.2 |
| 9 | heat shock protein HSP 90-beta | HSP90AB1 | gi|40556608 | 15 | 25 | 287 | −1.8 |
| 10 | dihydropyrimidinase-related protein 2 | DPYSL2 | gi|40254595 | 9 | 21 | 237 | −2.1 |
| 2 | dihydropyrimidinase-related protein 2 | DPYSL2 | gi|40254595 | 8 | 22 | 144 | −1.4 |
| 11 | ATP synthase, H+ transporting, mitochondrial F1 complex,alpha subunit, isoform 1 | ATP5A1 | gi|149029483 | 9 | 23 | 564 | −1.6 |
| 1 | alpha-enolase isoform 1 | ENO1 | gi|158186649 | 8 | 29 | 258 | −1.2 |
|
| |||||||
| 12 | Alpha-enolase 1 | ENO1 | gi: 56757324 | 2 | 6 | 46 | 1.8 |
| 1 | alpha-enolase isoform 1 | ENO1 | gi|158186649 | 8 | 29 | 258 | 1.4 |
| 13 | pyruvate kinase isozymes M1/M2 | PKM2 | gi|16757994 | 9 | 24 | 295 | 1.8 |
| 14 | pyruvate kinase isozymes M1/M2 | PKM2 | gi|16757994 | 12 | 37 | 372 | 2.0 |
| 15 | enolase 3 | ENO3 | gi|109468300 | 8 | 27 | 262 | 1.7 |
| 16 | ATP synthase subunit gamma, mitochondrial | ATP5C1 | gi|39930503 | 4 | 21 | 189 | 2.4 |
| 17 | Succinyl-CoA ligase [ADP-forming] subunit beta,mitochondrial | SUCLA2 | gi: 52788305 | 8 | 15 | 264 | 1.5 |
| 18 | Eno1 protein | ENO1 | gi|38649320 | 7 | 24 | 84 | 1.6 |
| 2 | dihydropyrimidinase-related protein 2 | DPYSL2 | gi|40254595 | 8 | 22 | 144 | 1.9 |
Figure 2The expression of significantly regulated proteins from membrane extracts of rat NAcc (P<0.05) comparing EC vs. IC basal expression (blue), IC stress (green), and EC stress (orange), which were analyzed by Progenesis SameSpots in CBB stained gels.
Proteins significantly regulated in the membrane fraction of rat NAcc in EC and IC rats.
| Spot ID no. | Protein name | Genesymbol | NCBI No. | Number of matched peptides | Coverage (%) | MOWSE score | Fold change |
|
| |||||||
| 1 | creatine kinase U-type,mitochondrial | CKMT1A | gi|60678254 | 9 | 21 | 746 | −1.6 |
| 2 | Rieske Fe-S protein precursor | UQCRFS1 | gi|206681 | 8 | 19 | 398 | −4.1 |
| 3 | voltage-dependent anion channel 1 | VDAC1 | gi|6755963 | 14 | 65 | 823 | −1.7 |
| 4 | NADH dehydrogenase [ubiquinone]iron-sulfur protein 2, mitochondrial. | NDUFS2 | gi|58865384 | 18 | 50 | 441 | −1.8 |
| 5 | cytochrome b-c1 complex subunit 2, mitochondrial | UQCRC2 | gi|55741544 | 14 | 39 | 512 | −1.8 |
| 6 | cytochrome b-c1 complex subunit 2, mitochondrial | UQCRC2 | gi|55741544 | 11 | 32 | 192 | −1.5 |
| 7 | rCG42519, isoform CRA_a (citrate synthase) | CS | gi|149029697 | 8 | 19 | 427 | −1.9 |
| 8 | ATP synthase, H+ transporting mitochondrialF1 complex, alpha 1 | ATP5A1 | gi|149029483 | 21 | 54 | 948 | −2.4 |
| 9 | ATPase, H+ transporting, lysosomal V1subunit A | ATP6V1A | gi|157819953 | 29 | 51 | 675 | −1.3 |
| 10 | voltage-dependent anion channel 1 | VDAC1 | gi|6755963 | 14 | 65 | 479 | −2.2 |
| 11 | tubulin, alpha 1 | TUBA1A | gi|6755901 | 14 | 42 | 591 | 1.5 |
|
| |||||||
| 12 | phosphoglycerate kinase 1 | PGK1 | gi|40254752 | 17 | 47 | 822 | −2.1 |
| 7 | citrate synthase | CS | gi|149029697 | 8 | 19 | 427 | −2.0 |
| 13 | ATP synthase, H+ transporting,mitochondrial F1complex | ATP5A1 | gi|149029483 | 22 | 53 | 1,160 | −1.7 |
| 14 | voltage-dependent anion channel 1 | VDAC1 | gi|6755963 | 12 | 57 | 702 | −2.0 |
| 15 | glyceraldehyde-3-phosphate dehydrogenase | GAPDH | gi|8393418 | 11 | 43 | 411 | −2.2 |
| 16 | pyruvate dehydrogenase E1 alpha 1 | PDHA1 | gi|57657 | 9 | 21 | 258 | −1.5 |
| 1 | creatine kinase U-type,mitochondrial | CKMT1A | gi|60678254 | 14 | 33 | 746 | −2.9 |
| 17 | ATP synthase, H+ transporting mitochondrialF1 complex, alpha 1 | ATP5A1 | gi|149029483 | 16 | 44 | 408 | −1.9 |
| 18 | 14-3-3 protein, gamma | YWHAG | gi|9507245 | 5 | 19 | 134 | −1.8 |
| 2 | Rieske Fe-S protein precursor | UQCRFS1 | gi|206681 | 8 | 19 | 398 | −3.2 |
| 19 | Serum albumin, Precursor | ALB | gi|124028612 | 12 | 20 | 482 | −1.2 |
| 20 | NADH dehydrogenase [ubiquinone] 1alpha 9, mitochondrial. | NDUFA1 | gi|81882598 | 15 | 43 | 445 | −1.8 |
| 8 | ATP synthase, H+ transporting mitochondrialF1 complex, alpha 1 | ATP5A1 | gi|149029483 | 21 | 54 | 948 | −2.2 |
| 21 | glyceraldehyde-3-phosphate dehydrogenase | GAPDH | gi|8393418 | 11 | 43 | 423 | −1.9 |
| 22 | rab GDI alpha | GDI1 | gi|396431 | 13 | 37 | 147 | 2.4 |
| 31 | tyrosine 3-monooxygenase/tryptophan5-monooxygenase activation protein,epsilon polypeptide, isoform CRA_a | YWHAE | gi|149053421 | 8 | 44 | 108 | 1.9 |
| 32 | tyrosine 3-monooxygenase/tryptophan5-monooxygenase activation protein,zeta polypeptide | YWHAZ | gi|6756041 | 14 | 56 | 323 | 1.5 (P = 0.06) |
|
| |||||||
| 23 | Unidentified | ||||||
| 24 | Septin-11 protein | SEPT11 | gi|38328220 | 8 | 14 | 266 | 1.7 |
| 25 | sorting and assembly machinerycomponent 50 | SAMM50 | gi|51948454 | 9 | 21 | 198 | 1.7 |
| 26 | Glutamate oxaloacetate transaminase 1 | GOT1 | gi|122065118 | 14 | 34 | 553 | 1.7 |
| 27 | glutamate dehydrogenase 1, mitochondrialprecursor | GLUD1 | gi|6980956 | 8 | 12 | 166 | 1.9 |
| 28 | elongation factor Tu, mitochondrialprecursor | TUFM | gi|157820845 | 11 | 27 | 416 | 2.0 |
| 29 | ARP1 actin-related protein 1 homolog A,centractin α | ACTR1A | gi|5031569 | 7 | 22 | 242 | 2.0 |
| 30 | N-ethylmaleimide sensitive fusion protein,isoformCRA_b | NSF | gi|149054471 | 22 | 28 | 354 | 1.4 |
Gene ontology terms for regulated proteins.
| Category | Term | Count | % |
| Genes | Fold enrich-ment | Bonferroni | Benjamini | FDR |
|
| |||||||||
|
|
| ||||||||
| GOTERM_CC_FAT GO: 0005743 | Mitochon-drial innermembrane | 7 | 53.84 | 1.47E-07 | UQCRC2, CKMT1A, ATP5A1, HSPD1, UQCRFS1, NDUFS2, VDAC1 | 22.49 | 1.25E-05 | 6.24E-06 | 1.58E-04 |
| GOTERM_CC_FAT GO: 0005740 | mitochondrial envelope | 7 | 53.84 | 9.36E-07 | UQCRC2, CKMT1A, ATP5A1, HSPD1, UQCRFS1, NDUFS2, VDAC1 | 16.42 | 7.95E-05 | 1.33E-05 | 0.001 |
|
|
| ||||||||
| GOTERM_BP_FAT GO: 0006119 | oxidative phosphorylation | 4 | 30.77 | 5.83E-05 | UQCRC2, ATP6V1A, ATP5A1, NDUFS2 | 46.01 | 0.016 | 0.0082 | 0.077 |
|
|
| ||||||||
| SP_PIR_KEYWORDS | respiratory chain | 3 | 23.08 | 8.66E-04 | UQCRC2, UQCRFS1, NDUFS2 | 62.52 | 0.062 | 0.015 | 0.90 |
| GOTERM_CC_FAT GO: 0005746 | mitochondrial respiratorychain | 3 | 23.08 | 0.0015 | UQCRC2, UQCRFS1, NDUFS2 | 46.09 | 0.12 | 0.011 | 1.68 |
|
|
| ||||||||
| SP_PIR_KEYWORDS | nucleotide-binding | 6 | 46.15 | 0.0024 | ATP6V1A, CKMT1A, ATP5A1, HSPD1, TUBA1A, HSPA8 | 5.27 | 0.16 | 0.025 | 2.49 |
|
|
| ||||||||
| GOTERM_CC_FAT GO: 0005759 | mitochondrial matrix | 4 | 30.77 | 0.001 | CS, ATP5A1, HSPD1, VDAC1 | 17.33 | 0.087 | 0.0083 | 1.15 |
| GOTERM_CC_FAT GO: 0031980 | mitochondrial lumen | 4 | 30.77 | 0.001 | CS, ATP5A1, HSPD1, VDAC1 | 17.33 | 0.087 | 0.0083 | 1.15 |
|
| |||||||||
|
|
| ||||||||
| GOTERM_BP_FAT GO: 0006091 | generation of precursor metabolites and energy | 8 | 47.06 | 1.82E-08 | NDUFA9, CS, PDHA1, ATP5A1, PGK1, UQCRFS1, GAPDH, ENO1 | 21.61 | 5.52E-06 | 5.52E-06 | 2.44E-05 |
| SP_PIR_KEYWORDS | glycolysis | 4 | 23.53 | 6.13E-06 | PDHA1, PGK1, GAPDH, ENO1 | 102.86 | 6.06E-04 | 3.03E-04 | 0.006785 |
|
|
| ||||||||
| GOTERM_BP_FAT GO: 0006091 | generation of precursor metabolites and energy | 8 | 47.06 | 1.82E-08 | NDUFA9, CS, PDHA1, ATP5A1, PGK1, UQCRFS1, GAPDH, ENO1 | 21.61 | 5.52E-06 | 5.52E-06 | 2.44E-05 |
| GOTERM_CC_FAT GO: 0005739 | mitochondrion | 10 | 58.82 | 7.04E-07 | YWHAZ, CKMT1A, NDUFA9, CS, PDHA1, ATP5A1, DPYSL2, UQCRFS1, YWHAE, VDAC1 | 7.35 | 5.63E-05 | 5.63E-05 | 7.48E-04 |
|
|
| ||||||||
| SMART SM00101: | 14_3_3 | 3 | 17.65 | 3.06E-06 | YWHAZ, YWHAG, YWHAE | 778.2 | 9.17E-06 | 9.17E-06 | 9.62E-04 |
| UP_SEQ_FEATURE site: | Interaction with phosphoserine on interacting protein | 3 | 17.65 | 1.38E-05 | YWHAZ, YWHAG, YWHAE | 481.84 | 9.08E-04 | 9.08E-04 | 0.014 |
|
|
| ||||||||
| GOTERM_CC_FAT GO: 0048770 | pigment granule | 3 | 17.65 | 0.0047 | HSP90AB1, YWHAZ, YWHAE | 26.93 | 0.31 | 0.046 | 4.93 |
| GOTERM_CC_FAT GO: 0042470 | melanosome | 3 | 17.65 | 0.0047 | HSP90AB1, YWHAZ, YWHAE | 26.93 | 0.31 | 0.046 | 4.93 |
|
| |||||||||
|
|
| ||||||||
| GOTERM_BP_FAT GO: 0006091 | generation of precursor metabolites and energy | 6 | 3.68 | 4.03E-07 | GOT1, PKM2, ATP5C1, ENO3, SUCLA2, ENO1 | 27.76 | 4.31E-05 | 4.31E-05 | 4.53E-04 |
| GOTERM_BP_FAT GO: 0006096 | glycolysis | 3 | 1.84 | 5.02E-04 | PKM2, ENO3, ENO1 | 77.07 | 0.052 | 0.026 | 0.56 |
Figure 3Top ten major biological functionsof regulated proteins comparing EC and IC basal expression (a), IC stress (b), EC stress (c) via IPA analysis.
Y-axis represents the –log (P value).
Cellular functions identified via IPA analysis.
| Category | Function Annotation | P-Value | Molecules | Number of Molecules |
|
| ||||
| Cell Death | cell death of neuroblastoma cell lines | 9.76E-06 | ATP5A1,ENO1,HSPA8,TUBA1A | 4 |
| Nucleic Acid Metabolism | biosynthesis of purine ribonucleotide | 2.48E-05 | ATP5A1,HSPD1,VDAC1 | 3 |
| Protein Folding | refolding of protein | 6.11E-05 | HSPA8,HSPD1 | 2 |
| Cell Death | cell death of tumor cell lines | 8.14E-05 | ATP5A1,ENO1,HSPA8,HSPD1,TUBA1A,UQCRFS1,VDAC1 | 7 |
| Nucleic Acid Metabolism | metabolism of nucleic acid componentor derivative | 9.03E-05 | ATP5A1,CS,DPYSL2,HSPD1,VDAC1 | 5 |
| Nucleic Acid Metabolism | synthesis of purine nucleotide | 2.09E-04 | ATP5A1,HSPD1,VDAC1 | 3 |
| Cellular Assembly and Organization | transport of synaptic vesicles | 8.74E-04 | DPYSL2,HSPA8 | 2 |
| Nucleic Acid Metabolism | synthesis of ATP | 9.78E-04 | HSPD1,VDAC1 | 2 |
|
| ||||
| Cell Death | cell death of tumor cell lines | 7.44E-07 | ALB,ATP5A1,ENO1,GAPDH,HSP90AB1,UQCRFS1,VDAC1,YWHAE,YWHAG,YWHAZ | 10 |
| Cancer | cholangiocarcinoma | 2.08E-05 | ALB,HSP90AB1,PGK1 | 3 |
| Carbohydrate Metabolism | glycolysis of cells | 2.21E-05 | ENO1,GAPDH,PGK1 | 3 |
| Free Radical Scavenging | synthesis of reactive oxygen species | 7.83E-05 | ALB,HSP90AB1,UQCRFS1,VDAC1,YWHAZ | 5 |
| Protein Trafficking | targeting of protein | 2.39E-04 | YWHAE,YWHAG,YWHAZ | 3 |
| Cancer | digestive organ tumor | 3.03E-04 | ALB,DPYSL2,ENO1,HSP90AB1,PGK1,YWHAE,YWHAG,YWHAZ | 8 |
| Free Radical Scavenging | production of reactive oxygen species | 3.28E-04 | HSP90AB1,UQCRFS1,VDAC1,YWHAZ | 4 |
| Neurological Disease | Leigh syndrome | 3.48E-04 | NDUFA9,PDHA1 | 2 |
| Gene Expression | binding of DNA | 3.69E-04 | ALB,GAPDH,YWHAE,YWHAG,YWHAZ | 5 |
| Nucleic Acid Metabolism | metabolism of nucleic acid component or derivative | 3.81E-04 | ATP5A1,CS,DPYSL2,PGK1,VDAC1 | 5 |
| Dermatological Diseases and Conditions | Psoriasis | 7.12E-04 | CKMT1A,GAPDH,UQCRFS1,VDAC1,YWHAE | 5 |
| Inflammatory Disease | acute respiratory distress syndrome | 7.26E-04 | ALB,GAPDH | 2 |
| Cell Death | cell death of neuroblastoma cell lines | 8.19E-04 | ATP5A1,ENO1,YWHAE | 3 |
|
| ||||
| Amino Acid Metabolism | catabolism of acidic amino acid | 1.42E-05 | GLUD1,GOT1 | 2 |
| Nucleic Acid Metabolism | metabolism of nucleic acid component or derivative | 9.03E-05 | ATP5C1,DPYSL2,NSF,PKM2,SUCLA2 | 5 |
| Small Molecule Biochemistry | metabolism of dicarboxylic acid | 2.00E-04 | GOT1,SUCLA2 | 2 |
| Nucleic Acid Metabolism | metabolism of nucleoside triphosphate | 2.22E-04 | ATP5C1,NSF,PKM2 | 3 |
| Amino Acid Metabolism | synthesis of L-amino acid | 3.10E-04 | GLUD1,GOT1 | 2 |
| Carbohydrate Metabolism | glycolysis of cells | 8.09E-04 | ENO1,PKM2 | 2 |
Figure 4Top ten major canonical pathways of regulated proteins comparing EC and IC basal expression (a), IC stress (b), EC stress (c) via IPA analysis.
Y-axis represents the –log (P value).
Canonical pathways identified via IPA analysis.
| Ingenuity Canonical Pathways | −log(P-value) | Ratio | Molecules | |||
|
| ||||||
| Oxidative Phosphorylation | 7.08 | 3.14E-02 | ATP5A1,UQCRC2,NDUFS2,UQCRFS1,ATP6V1A | |||
| Mitochondrial Dysfunction | 5.42 | 2.30E-02 | ATP5A1,UQCRC2,NDUFS2,UQCRFS1 | |||
| Aldosterone Signaling in Epithelial Cells | 2.12 | 1.16E-02 | HSPA8,HSPD1 | |||
| Phenylalanine, Tyrosine and Tryptophan Biosynthesis | 1.84 | 1.49E-02 | ENO1 | |||
| Pantothenate and CoA Biosynthesis | 1.79 | 1.64E-02 | DPYSL2 | |||
| Glyoxylate and Dicarboxylate Metabolism | 1.75 | 8.93E-03 | CS | |||
| Protein Ubiquitination Pathway | 1.71 | 7.46E-03 | HSPA8,HSPD1 | |||
| Purine Metabolism | 1.65 | 4.98E-03 | ATP5A1,HSPD1 | |||
| Citrate Cycle | 1.61 | 1.75E-02 | CS | |||
| Urea Cycle and Metabolism of Amino Groups | 1.57 | 1.28E-02 | CKMT1A/CKMT1B | |||
|
| ||||||
| Glycolysis/Gluconeogenesis | 5.65 | 3.08E-02 | PGK1,PDHA1,ENO1,GAPDH | |||
| PI3K/AKT Signaling | 5.12 | 2.88E-02 | YWHAG,YWHAE,HSP90AB1,YWHAZ | |||
| Mitochondrial Dysfunction | 4.91 | 2.30E-02 | PDHA1,NDUFA9,ATP5A1,UQCRFS1 | |||
| Cell Cycle: G2/M DNA Damage Checkpoint Regulation | 4.82 | 6.12E-02 | YWHAG,YWHAE,YWHAZ | |||
| Myc Mediated Apoptosis Signaling | 4.44 | 4.92E-02 | YWHAG,YWHAE,YWHAZ | |||
| ERK5 Signaling | 4.37 | 4.69E-02 | YWHAG,YWHAE,YWHAZ | |||
| IGF-1 Signaling | 3.78 | 2.83E-02 | YWHAG,YWHAE,YWHAZ | |||
| 14-3-3-mediated Signaling | 3.54 | 2.46E-02 | YWHAG,YWHAE,YWHAZ | |||
| p70S6K Signaling | 3.49 | 2.26E-02 | YWHAG,YWHAE,YWHAZ | |||
| Oxidative Phosphorylation | 3.30 | 1.89E-02 | NDUFA9,ATP5A1,UQCRFS1 | |||
|
| ||||||
| Phenylalanine, Tyrosine and Tryptophan Biosynthesis | 6.48 | 4.48E-02 | ENO1,ENO3,GOT1 | |||
| Glycolysis/Gluconeogenesis | 4.30 | 2.31E-02 | PKM2,ENO1,ENO3 | |||
| Glutamate Metabolism | 3.31 | 2.60E-02 | GLUD1,GOT1 | |||
| Purine Metabolism | 2.83 | 7.46E-03 | PKM2,NSF,ATP5C1 | |||
| Arginine and Proline Metabolism | 2.77 | 1.13E-02 | GLUD1,GOT1 | |||
| D-glutamine and D-glutamate Metabolism | 2.47 | 3.85E-02 | GLUD1 | |||
| Pantothenate and CoA Biosynthesis | 1.79 | 1.64E-02 | DPYSL2 | |||
| Citrate Cycle | 1.61 | 1.75E-02 | SUCLA2 | |||
| Urea Cycle and Metabolism of Amino Groups | 1.57 | 1.28E-02 | GLUD1 | |||
| Nitrogen Metabolism | 1.52 | 8.40E-03 | GLUD1 | |||
Figure 5Significant networks identified via IPA analysis of (a) basal EC vs. IC protein expression, (b and c) IC stress, and (d) EC stress.
Red symbols represent upregulated and green denote downregulated proteins. Asterisks (*) denote multiple spots mapping to the same protein.
Figure 6Functional assay of ATP synthase activity and ATP5B quantity.
Bars represent mean (± SEM) amount of ATP synthase activity in mM/min (a) and quantity in OD/min (b) of ATP synthase. Asterisk (*) represents statistically significant difference from control. Bottom panels depict correlation of activity and quantity as measured from the kit (c) and activity and quantity of ATP5C1 as measured from the 2D gel (d). Circles represent IC rats and triangles represent EC rats. Controls are white symbols and Stress groups are red. Solid line depicts a significant correlation for EC rats and dashed line depicts a lack of correlation in IC rats.
Figure 7Regulated energy metabolism proteins are CREB targets.
The diagram depicts significantly regulated proteins in the glycolysis, TCA and electron transport pathways. The thirteen significantly regulated proteins are shown as large symbols. In addition, 12 of the 13 regulated proteins are from CREB target genes (shown as red symbols).